Sustained Improvements In Signs And Symptoms Of Active Ankylosing Spondylitis And Reassuring Safety With Secukinumab 300mg: 3-Year Results From A Phase 3 Study
JCR-JOURNAL OF CLINICAL RHEUMATOLOGY（2018）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined